ID
77
Description
Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML) Inclusion criteria: - cytological confirmation of AML - relapsed disease following first CR of 1 month(30days) to 24 months(730days). The time from first relapse to study entry (start of first course of induction chemotherapy) must be no longer than 30days - confirmation of FLT-3 activating mutation positive status after point of initial relapse - aged 18 years or older - written informed consent - ability to understand and comply with study restrictions - no comorbid conditions that would limit life expectancy to less than 3 months - ECOG Performance Score of 0, 1,or 2 - women must be neither pregnant nor lactating, and either of non-childbearing potential or using adequate contraception with a negative pregnancy test at study entry Exclusion criteria - bilirubin more than 2x ULN - ALT/AST more than 3x ULN - serum creatinine more than 1.5 mg/dL - resting ejection fraction of left ventricle l less than 45% (applies only to patients scheduled to receive mitoxantrone, etoposide, and cytarabine (MEC) - untreated or progressive infection - any physical or psychiatric cdtn that may compromise participation in the study - known CNS involvement with AML - any previous treatment with a FLT-3 inhibitor - requires current treatment for HIV with protease inhibitors - active GI ulceration or bleeding - use of an investigational drug that is not expected to be cleared by the start of CEP-701 treatment
Keywords
Versions (3)
- 11/18/11 11/18/11 -
- 3/26/14 3/26/14 - Martin Dugas
- 9/17/21 9/17/21 -
Uploaded on
November 18, 2011
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility NCT00079482 AML
Eligibility
- StudyEvent: Eligibility
Description
Exclusion criteria
Description
Bilirubin
Data type
boolean
Description
ALT / AST
Data type
boolean
Description
Serum creatinine
Data type
boolean
Description
Ejection fraction
Data type
boolean
Description
Infection
Data type
boolean
Description
Major physical or psychiatric condition
Data type
boolean
Description
CNS involvement
Data type
boolean
Description
Previous FLT-3 inhibitor
Data type
boolean
Description
HIV treatment
Data type
boolean
Description
Gastrointestinal ulceration or bleeding
Data type
boolean
Description
Other investigational drug
Data type
boolean
Description
Medical Concepts
Description
Diagnosis
Data type
string
Alias
- UMLS CUI
- C0011900
- SNOMED CT 2010_0731
- 439401001
Description
AML
Data type
string
Alias
- UMLS CUI
- C0023467
- SNOMED CT 2010_0731
- 91861009
- MedDRA 13.1
- 10000884
Description
Relapse
Data type
string
Alias
- UMLS CUI
- C0035020
- SNOMED CT 2010_0731
- 263855007
- MedDRA 13.1
- 10000884
Description
FLT3 gene mutation analysis
Data type
string
Alias
- UMLS CUI
- C1953284
Description
Age
Data type
string
Alias
- UMLS CUI
- C0001779
- SNOMED CT 2010_0731
- 102518004
Description
Compliance
Data type
string
Alias
- UMLS CUI
- C1321605
- SNOMED CT 2010_0731
- 405078008
Description
Life expectancy
Data type
string
Alias
- UMLS CUI
- C0023671
- LOINC Version 232
- LP75025-4
Description
ECOG performance status
Data type
string
Alias
- SNOMED CT 2010_0731
- 423740007
Description
pregnant
Data type
string
Alias
- UMLS CUI
- C0549206
- MedDRA 13.1
- 10036586
Description
Lactation
Data type
string
Alias
- UMLS CUI
- C0006147
- MedDRA 13.1
- 10006247
Description
Bilirubin
Data type
string
Alias
- SNOMED CT 2010_0731
- 79706000
- UMLS CUI
- C0011221
- MedDRA Version 13.1
- 10004683
- LOINC
- 1975-2
Description
AST
Data type
string
Alias
- SNOMED CT 2010_0731
- 26091008
- UMLS CUI
- C0004002
- MedDRA Version 13.1
- 10003543
- LOINC
- 1920-8
Description
ALT
Data type
string
Alias
- SNOMED CT 2010_0731
- 56935002
- UMLS CUI
- C0001899
- MedDRA Version 13.1
- 10001844
- LOINC
- 1742-6
Description
Creatinine
Data type
string
Alias
- UMLS CUI
- C0010294
- SNOMED CT 2010_0731
- 15373003
- LOINC
- 38483-4
- MedDRA 13.1
- 10011358
Description
Cardiac ejection fraction
Data type
string
Alias
- UMLS CUI
- C0232174
- SNOMED CT 2010_0731
- 70822001
Description
Infection
Data type
string
Alias
- UMLS CUI
- C0021311
- SNOMED CT 2010_0731
- 257551009
- MedDRA Version 13.1
- 10021789
Description
CNS involvement
Data type
string
Alias
- UMLS CUI
- C0449389
- SNOMED CT 2010_0731
- 260766009
Description
Pharmaceutical Preparations
Data type
string
Alias
- UMLS CUI
- C0013227
Description
HIV negative
Data type
string
Alias
- UMLS CUI
- C0481430
- SNOMED CT 2010_0731
- 143223008
Description
Gastrointestinal ulcer
Data type
string
Alias
- UMLS CUI
- C0237938
- SNOMED CT 2010_0731
- 40845000
- MedDRA Version 13.1
- 10061459
Description
Gastrointestinal hemorrhage
Data type
string
Alias
- UMLS CUI
- C0017181
- SNOMED CT 2010_0731
- 74474003
- MedDRA Version 13.1
- 10017936
Description
Enrollment
Data type
string
Alias
- UMLS CUI
- C1516879
Similar models
Eligibility
- StudyEvent: Eligibility
439401001 (SNOMED CT 2010_0731)
91861009 (SNOMED CT 2010_0731)
10000884 (MedDRA 13.1)
263855007 (SNOMED CT 2010_0731)
10000884 (MedDRA 13.1)
102518004 (SNOMED CT 2010_0731)
405078008 (SNOMED CT 2010_0731)
10036586 (MedDRA 13.1)
10006247 (MedDRA 13.1)
70822001 (SNOMED CT 2010_0731)
257551009 (SNOMED CT 2010_0731)
10021789 (MedDRA Version 13.1)
260766009 (SNOMED CT 2010_0731)
143223008 (SNOMED CT 2010_0731)
40845000 (SNOMED CT 2010_0731)
10061459 (MedDRA Version 13.1)
74474003 (SNOMED CT 2010_0731)
10017936 (MedDRA Version 13.1)